Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation

Subjects

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1

References

  1. Fialkow PJ, Thomas ED, Bryant JI, Neiman PE . Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1971; 1: 251–255.

    Article  CAS  Google Scholar 

  2. Wiseman DH . Donor cell leukemia: a review. Biol Blood Marrow Transplant 2011; 17: 771–789.

    Article  Google Scholar 

  3. Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S et al. Development of leukemia in donor cells after allogeneic stem cell transplantation—a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 2005; 90: 969–975.

    PubMed  Google Scholar 

  4. Dietz AC, DeFor TE, Brunstein CG, Wagner JE Jr . Donor-derived myelodysplastic syndrome and acute leukaemia after allogeneic haematopoietic stem cell transplantation: incidence, natural history and treatment response. Br J Haematol 2014; 166: 209–212.

    Article  Google Scholar 

  5. Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol 2007; 86: 269–274.

    Article  Google Scholar 

  6. Chonabayashi K, Kondo T, Yamamoto K, Tanaka Y, Nagai Y, Hishizawa M et al. Successful use of second cord blood transplantation to achieve long-term remission in cord blood donor cell-derived AML harboring a FLT3-ITD and an NPM1 mutation. Bone Marrow Transplant 2012; 47: 1252–1253.

    Article  CAS  Google Scholar 

  7. Iizuka A, Komiyama M, Tai S, Oshita C, Kurusu A, Kume A et al. Identification of cytomegalovirus (CMV)pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients. Immunol Lett 2011; 135: 64–73.

    Article  CAS  Google Scholar 

  8. Kanda Y . Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant 2013; 48: 452–458.

    Article  CAS  Google Scholar 

  9. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T et al. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2011; 41: 139–147.

    Article  Google Scholar 

  10. Bielorai B, Deeg HJ, Weintraub M, Neumann Y, Rosner E, Amariglio N et al. B-cell lymphoma developing in the donor 9 years after donor-origin acute myeloid leukemia post bone marrow transplantation. Bone Marrow Transplant 2003; 31: 931–934.

    Article  CAS  Google Scholar 

  11. Xiao H, Shi J, Luo Y, Tan Y, He J, Xie W et al. First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. Blood 2011; 117: 5257–5260.

    Article  CAS  Google Scholar 

  12. Genovese G, Kahler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med 2014; 371: 2477–2487.

    Article  Google Scholar 

  13. Rossi DJ, Bryder D, Zahn JM, Ahlenius H, Sonu R, Wagers AJ et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA 2005; 102: 9194–9199.

    Article  CAS  Google Scholar 

  14. Yasuda T, Ueno T, Fukumura K, Yamato A, Ando M, Yamaguchi H et al. Leukemic evolution of donor-derived cells harboring IDH2 and DNMT3A mutations after allogeneic stem cell transplantation. Leukemia 2014; 28: 426–428.

    Article  CAS  Google Scholar 

  15. Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M et al. PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med 2015; 372: 311–319.

    Article  Google Scholar 

Download references

Acknowledgements

We thank all the staff at the hospitals and centers who provided precise data via the registry of the Japan Society for Hematopoietic Cell Transplantation. A script kindly provided by Dr Yoshinobu Kanda, Saitama Medical Center, Jichi Medical University was used for the data manipulation. We thank Dr Julian Tang of the Department of Education for Clinical Research, National Center for Child Health and Development for proofreading and editing this manuscript. This work was supported in part by a Research Grant for Allergic Disease and Immunology from the Japanese Ministry of Health, Labor and Welfare.

Author contributions

MK is the principal investigator and takes primary responsibility for the paper. MK, TY, KM, RS, HN, S Taniguchi and TF designed the research. RS, S Takahashi, KI, CN, TI and YA recruited the patients and collected the data. MK, TY, KM, RS, HN, S Taniguchi and TF analyzed the data and wrote the manuscript. All authors discussed the results and commented on the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Kato.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on the Leukemia website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kato, M., Yamashita, T., Suzuki, R. et al. Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation. Leukemia 30, 1742–1745 (2016). https://doi.org/10.1038/leu.2016.23

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2016.23

This article is cited by

Search

Quick links